![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Nagaraja Archana S Sadaoui Nouara C Lutgendorf Susan K Ramondetta Lois M Sood Anil K
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1359-1363
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Evidence for perioperative β-blockers questioned
Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The primacy of β-blockers for hypertension is challenged
Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
UK NICE advise a block on β-blockers
Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Evidence lacking for benefit of perioperative β-blockers and statins
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :